Compare AbCellera Biologics Inc (ABCL) vs Microchip Technology Inc. (MCHP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Microchip Technology Inc. — how do they compare? AbCellera Biologics Inc trades at $9.03 (market cap $2.99B), while Microchip Technology Inc. trades at $82.22 (market cap $43.99B). The key difference: Microchip Technology Inc. is far larger — about 14.7× AbCellera Biologics Inc's market cap, and Microchip Technology Inc. pays a 2.25% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | MCHP | |
|---|---|---|
Market Cap | $2.99B | $43.99B |
Sector | Health | Technology |
52-Week High | $9.76 | $102.97 |
52-Week Low | $2.78 | $49.02 |
Enterprise Value | $2.58B | $49.12B |
Dividend Yield | — | 2.25% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Microchip Technology Inc.
Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Read more on MCHP →
